NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 237 filers reported holding NEKTAR THERAPEUTICS in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $70,200 | -84.0% | 22,000 | -81.0% | 0.01% | -90.4% |
| Q2 2022 | $439,000 | -88.5% | 115,600 | -83.8% | 0.05% | -51.9% |
| Q1 2022 | $3,834,000 | +989.2% | 711,400 | +2636.2% | 0.11% | +1442.9% |
| Q4 2021 | $352,000 | +3.2% | 26,000 | +36.8% | 0.01% | -30.0% |
| Q3 2021 | $341,000 | -84.5% | 19,000 | -82.7% | 0.01% | -81.5% |
| Q1 2021 | $2,200,000 | +56.7% | 110,000 | +33.3% | 0.05% | +100.0% |
| Q4 2020 | $1,404,000 | +20.8% | 82,500 | +17.9% | 0.03% | -35.7% |
| Q3 2020 | $1,162,000 | – | 70,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Strong Tower Advisory Services | 404,972 | $6,913,000 | 4.02% |
| GREAT POINT PARTNERS LLC | 504,691 | $9,064,000 | 2.11% |
| Camber Capital Management LP | 3,750,000 | $67,350,000 | 2.07% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,901,000 | 1.50% |
| Rhenman & Partners Asset Management AB | 950,000 | $17,062,000 | 1.20% |
| MAVERICK CAPITAL LTD | 5,838,426 | $104,858,000 | 1.06% |
| Birchview Capital, LP | 72,000 | $1,293,000 | 0.88% |
| Bellevue Group AG | 4,594,656 | $82,519,000 | 0.84% |
| CM Management, LLC | 50,000 | $898,000 | 0.67% |
| Duquesne Family Office | 1,000,000 | $17,960,000 | 0.58% |